New England Journal of Medicine

Vol. 394, Issue 13 Issue 13 2026
22
Articles

Articles in this Issue

Minocycline-Induced Hyperpigmentation

Aarti Maharaj, Michael Omar Apr 02, 2026 10.1056/nejmicm2513782

Left Atrial Appendage Closure — Another Overused Method in Cardiology?

Petr Widimský Apr 02, 2026 pp. 1336-1338 10.1056/nejme2518067

More Options for Gene Editing in Hemoglobinopathies

Franco Locatelli Apr 02, 2026 pp. 1338-1340 10.1056/nejme2602194

Simulating and Teaching the Physiology of Pulsus Paradoxus

Rona Yu, Glen Cook, J. Edwin Atwood Apr 02, 2026 pp. 1347-1349 10.1056/nejmc2518685

Functional Dyspepsia

Apr 02, 2026 pp. 1349-1350 10.1056/nejmc2601477

Liver Transplantation in Alcohol-Related Liver Disease

Christos P. Kotanidis, Teresa C. Rice, Shimul A. Shah et al. Apr 02, 2026 pp. 1341-1344 10.1056/nejmclde2506067

The Fetal-to-Adult Hemoglobin Switch — Mechanism and Therapy

Apr 02, 2026 pp. 1352-1352 10.1056/nejmx250010

The Age Illusion — Limitations of Chronologic Age in Medicine

Martin G. Lee Apr 02, 2026 pp. 1251-1253 10.1056/nejmp2516973

GLP-1 Receptor Agonists

Clifford J. Rosen, Julie R. Ingelfinger Apr 02, 2026 pp. 1313-1324 10.1056/nejmra2500106

Trastuzumab Deruxtecan in Residual HER2-Positive Early Breast Cancer

Apr 02, 2026 pp. 1352-1352 10.1056/nejmx260006

Left Atrial Appendage Closure or Medical Therapy in Atrial Fibrillation

Ulf Landmesser, Carsten Skurk, Paulus Kirchhof et al. Apr 02, 2026 pp. 1270-1280 10.1056/nejmoa2513310

Therapy’s Conversion — <i>Chiles v. Salazar</i> ’s Threat to Mental Health Treatment and Standards of Care

Michael R. Ulrich Apr 02, 2026 pp. 1253-1255 10.1056/nejmp2516723

Discontinuation of Beta-Blocker Therapy after Myocardial Infarction

Ki Hong Choi, Danbee Kang, Weon Kim et al. Apr 02, 2026 pp. 1302-1312 10.1056/nejmoa2601005

Clinical Examination of the Lumbar Spine

Alan H. Daniels, Daniel Alsoof, Sarah Criddle et al. Apr 02, 2026 10.1056/nejmvcm2402306

Too Much of a Good Thing

Mark Wijnen, N. Chantal Peltenburg, Dieuwertje Augustijn et al. Apr 02, 2026 pp. 1326-1332 10.1056/nejmcps2510060

CRISPR-Cas12a Gene Editing of <i>HBG1</i> and <i>HBG2</i> Promoters to Treat Sickle Cell Disease

Rabi Hanna, Haydar Frangoul, Luis Pineiro et al. Apr 02, 2026 pp. 1281-1291 10.1056/nejmoa2415550

Enfortumab Vedotin plus Pembrolizumab as Perioperative Therapy

Parminder Singh, Seth P. Lerner Apr 02, 2026 pp. 1334-1336 10.1056/nejme2515777

Pemphigus Foliaceus

Apr 02, 2026 pp. 1350-1351 10.1056/nejmc2509905

CRISPR-Cas12a Gene Editing of <i>HBG1</i> and <i>HBG2</i> Promoters to Treat β-Thalassemia

Haydar Frangoul, Rabi Hanna, Mark C. Walters et al. Apr 02, 2026 pp. 1292-1301 10.1056/nejmoa2501277

Physicians, Corporatization, and the Unmeasured Quality of Care

Lawrence P. Casalino Apr 02, 2026 pp. 1249-1251 10.1056/nejmp2415488

Digital Twin–Guided Ablation for Ventricular Tachycardia

Jonathan Chrispin, Adityo Prakosa, Eugene Kholmovski et al. Apr 02, 2026 pp. 1345-1347 10.1056/nejmc2517822

Hepatic Arterial Buffer Response

Tushar Kumar, Sakura M. Noda Apr 02, 2026 pp. 1325-1325 10.1056/nejmicm2516362

All Issues

Journal Info

Publisher Massachusetts Medical Society
ISSN 0028-4793
E-ISSN 0096-6762
Subject Social Sciences
Language English
View Full Journal Page